Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
about
Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndromeRole of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineeringEnhancement of endothelialisation of coronary stents by laser surface engineering.Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model.In vivo capture and label-free detection of early metastatic cells.First step toward near-infrared continuous glucose monitoring: in vivo evaluation of antibody coupled biomaterials.Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy.A fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell functionDevelopment of a rabbit model for a preclinical comparison of coronary stent types in-vivo.Oligonucleotide biofunctionalization enhances endothelial progenitor cell adhesion on cobalt/chromium stents.Vascular injury and repair: a potential target for cell therapies.Mussel-inspired cell-adhesion peptide modification for enhanced endothelialization of decellularized blood vessels.Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.The Role of Synthetic Extracellular Matrices in Endothelial Progenitor Cell Homing for Treatment of Vascular Disease.In situ Endothelialization: Bioengineering Considerations to Translation.Nanomaterial coatings applied on stent surfaces.Silent information regulator 1 (SIRT1) promotes the migration and proliferation of endothelial progenitor cells through the PI3K/Akt/eNOS signaling pathway.Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCIKnitting for heart valve tissue engineering.Surface design for in situ capture of endothelial progenitor cells: VEGF-bound surface architecture and behaviors of cultured mononuclear cells.First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.Endothelial nitric oxide synthase overexpressing human early outgrowth cells inhibit coronary artery smooth muscle cell migration through paracrine functions.In vivo assessment of two endothelialization approaches on bioprosthetic valves for the treatment of chronic deep venous insufficiency.Valve Tissue Engineering with Living Absorbable Threads.Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis.Perinatal Tissue-Derived Endothelial Progenitor Cells
P2860
Q24202607-1B821593-FD64-43D3-924B-0547F1F69998Q33649957-A74FC95A-9032-4CE9-98D1-AD555A6C7592Q34987708-EDB58A76-F18B-42EF-9D20-F5E6753729C9Q35079541-EB2510BA-B7A0-43DD-85B0-E71AD5320483Q36040727-D66F5899-FC4A-4E19-AFCA-04B316622542Q37071456-134EE5D0-250A-43A9-A82B-49AA76A9DA93Q37249147-1BB2762A-65EC-4259-8624-6D2EB74CD583Q37294925-856C8E2C-B71F-4971-BD56-DB90A3309866Q37399608-D898DBC0-5ADE-46A2-A464-647506A0B16EQ38300227-0834F9C5-5E6B-4F61-80DE-71CEE40D6A1AQ38326653-FA0892B8-15DF-4C1F-A8D4-C5EB7C92B40FQ38438200-941A8701-9FCE-4205-B9B9-C9448F9BB2A8Q38522829-C0B59933-6E59-4C50-BCD7-8ECA269F7402Q38553350-C5AB0447-74F8-447E-AEC2-123411E46CC0Q38605831-A166543C-6BF5-4430-84D4-21B5E9021BE6Q38816692-1A2096B1-3009-4906-984C-209E1950D8A9Q40926121-8296EF16-B3D9-488F-A3E9-CF9530A051B5Q42290489-1BD4B34E-7AAD-4A51-9217-C12117128DB5Q42378633-7D09C8CB-5C22-4DF3-8AFB-A080C4E1A2B4Q44565677-4611475B-2F2E-43B9-A489-4211BBF43947Q45918764-0C91A174-6831-4178-9959-7D29A22222CEQ49989369-57BF29F5-DAAA-4B49-9E1E-D0449F1B140CQ51136296-F08004CA-D1CF-430F-9A33-4E1ABE7016DAQ51167306-54095EAD-3920-4FAE-846E-15F4D9294764Q53002487-DBEB9797-64CB-4F2E-86C3-FB4B5543DF3FQ57913855-6507B340-A0F2-43AE-ACEC-29B836D75D3F
P2860
Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Stent coated with antibody aga ...... reduces neointimal formation.
@en
Stent coated with antibody aga ...... reduces neointimal formation.
@nl
type
label
Stent coated with antibody aga ...... reduces neointimal formation.
@en
Stent coated with antibody aga ...... reduces neointimal formation.
@nl
prefLabel
Stent coated with antibody aga ...... reduces neointimal formation.
@en
Stent coated with antibody aga ...... reduces neointimal formation.
@nl
P2093
P1476
Stent coated with antibody aga ...... reduces neointimal formation.
@en
P2093
Chan-Koo Kang
Han-Mo Yang
Hyo-Soo Kim
Hyun-Jai Cho
Hyun-Ju Cho
Jonghanne Park
San Kyeong
Wonseok Choe
Yoon-Sik Lee
P304
P356
10.1161/ATVBAHA.111.226134
P407
P577
2011-10-20T00:00:00Z